7,400,000 Shares of Common Stock Xeris Pharmaceuticals, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • June 29th, 2020 • Xeris Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 29th, 2020 Company Industry Jurisdiction
Xeris Pharmaceuticals, Inc. 5.00% Convertible Senior Notes due 2025 UNDERWRITING AGREEMENTUnderwriting Agreement • June 29th, 2020 • Xeris Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 29th, 2020 Company Industry Jurisdiction